Edition:
United States

Profile: Alliance Pharma PLC (ALAPH.L)

ALAPH.L on London Stock Exchange

59.00GBp
19 Oct 2017
Change (% chg)

2.00 (+3.51%)
Prev Close
57.00
Open
58.00
Day's High
59.00
Day's Low
58.00
Volume
295,230
Avg. Vol
841,077
52-wk High
60.00
52-wk Low
41.33

Alliance Pharma plc is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in acquisition, marketing and distribution of pharmaceutical products. The Company operates in various business areas, such as Hydromol, secondary care, community and consumer products, established products and international. The Company's therapeutic areas of focus include cardiovascular, central nervous system, child health, consumer health, dermatology, endocrinology, gastroenterology, obstetrics and gynecology, oral health, oncology, stoma care, toxicology and travel health. The Company's product categories include prescription only medicines, over the counter medications, medical devices, cosmetics and nutritional supplements. The Company's products include SkinSafe, Lift Plus, AbsorbaGel, DeoGel, LaVera, ClearWay, Gelclair, ImmuCyst 81mg, Hydromol, MacuShield, Lypsyl, Anbesol Adult Strength Gel, MolluDab and Ashton & Parsons Infants' Powders.

Company Address

Alliance Pharma PLC

Avonbridge House, Bath Road
CHIPPENHAM     SN15 2BB
P: +441249.466966
F: +441249.466977

Company Web Links